Christoph Zielinski

8PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 19, 2024
Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON).

Joshua Tobias, Marina Maglakelidze, Zoran Andrić

|Oct 18, 2023
Cetuximab every 2 weeks versus standard weekly dosing administration schedule.

Carsten Bokemeyer, Fortunato Ciardiello, Olivier Dubreuil

|Aug 25, 2023
Interactions of EGFR/PTEN/mTOR-Pathway Activation and Estrogen Receptor Expression in Cervical Cancer.

Thomas Bartl, Christoph Grimm, Robert M Mader

|Jul 25, 2023
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.

Javier Pascual, Miguel Gil-Gil, Paula Proszek

Pageof 2